Quantitative RT-PCR:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Cell Culture:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Activity Assay:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Flow Cytometry:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Control:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Staining:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Fluorescence:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Purification:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Generated:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Western Blot:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Activation Assay:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Membrane:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Stripping Membranes:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
CRISPR:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Isolation:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
Labeling:Article Title: TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome
Article Snippet: One dpf larvae were manually dechorionated at 24 hpf and treated for 24 h by bath immersion with the TKIs nilotinib (#HY-10159, 1 μM), imatinib (#HY-15463, 1 μM and 10 μM), dasatinib (#HY-10181, 0.1 μM and 1 μM), bosutinib (#HY-10158, 0.1 μM and 1 μM) and ponatinib (#HY-12047, 0.1 μM and 1 μM), all from MedChemExpress, diluted in egg water supplemented with 0.1% DMSO.
|